HomeIBRX • NASDAQ
add
Immunitybio Inc
Previous close
$2.56
Day range
$2.38 - $2.60
Year range
$2.38 - $10.53
Market cap
1.77B USD
Avg Volume
5.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.11M | 7,346.34% |
Operating expense | 86.36M | 7.66% |
Net income | -85.73M | 10.31% |
Net profit margin | -1.40K | 98.80% |
Earnings per share | -0.12 | — |
EBITDA | -75.80M | -0.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 130.37M | -31.31% |
Total assets | 364.57M | -15.69% |
Total liabilities | 1.11B | 31.51% |
Total equity | -744.16M | — |
Shares outstanding | 696.83M | — |
Price to book | -2.39 | — |
Return on assets | -49.61% | — |
Return on capital | -69.65% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -85.73M | 10.31% |
Cash from operations | -98.76M | -13.00% |
Cash from investing | 65.03M | 516.05% |
Cash from financing | 15.58M | -93.44% |
Net change in cash | -18.14M | -113.49% |
Free cash flow | -71.97M | -26.40% |
About
CEO
Founded
2014
Website
Employees
672
